MARKET

AEMD

AEMD

Aethlon Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.200
-0.120
-5.17%
After Hours: 2.250 -0.07 -3.02% 19:09 02/26 EST
OPEN
2.280
PREV CLOSE
2.320
HIGH
2.330
LOW
2.111
VOLUME
274.81K
TURNOVER
--
52 WEEK HIGH
3.730
52 WEEK LOW
1.180
MARKET CAP
26.67M
P/E (TTM)
-3.0869
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Chronic Traumatic Encephalopathy (CTE) Market Analysis, Growth, Opportunities, Inudstry Trends, Price and Report 2020-2027
Japan, Japan, Fri, 26 Feb 2021 01:28:09 / Comserve Inc. / -- Competitive Analysis: Eustralis Pharmaceuticals Ltd, Eli Lilly, Prothena Corp Plc, Amarantus...
Comserve · 3d ago
Exosome Diagnostic and Therapeutics Market Size 2021 Global Gross Margin Analysis, Growth,Share, Industry Leading Players Update, Development History, Business Prospect and Industry Research Report 2025
Feb 24, 2021 (The Expresswire) -- Global Exosome Diagnostic and Therapeutics Market Research report discusses the market growth drivers and challenges that...
The Express Wire · 5d ago
Global Exosome Diagnostics and Therapeutics Market Size 2021-2026 By Development History, Growth Factor, Prominent Players Updates, Business Analysis, Share Estimation till 2026 | Industry Research Biz
The Express Wire · 02/17 07:32
Exosome Diagnostic and Therapeutics Market 2021 to 2025 Growth Factors, Market Characteristics, Opportunities By Type Analysis and Forecast
Feb 16, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" “Exosome Diagnostic and Therapeutics...
The Express Wire · 02/16 09:58
Medical Membrane Devices Market Size To 2026 – Global Industry Outlook, Growth Opportunities, Trends and Forecast with Top Players Analysis | Market Growth Reports
The Express Wire · 02/15 11:37
AEMD: Company Provides Update on Studies and Business Outlook
By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Aethlon Medical, Inc. (NASDAQ:AEMD) reported 3Q FY2021 results last night and provided an updated outlook on the two clinical studies underway. The company is developing products to diagnose and tr...
Zacks Small Cap Research · 02/11 11:10
DJ Aethlon Medical, Inc. CEO Dr. Chuck Fisher on Q3 2021 Results -- Earnings Call Transcript >AEMD
Dow Jones · 02/11 02:11
10-Q: AETHLON MEDICAL INC
(EDGAR Online via COMTEX) -- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. The following discussion of our...
Edgar Online - (EDG = 10Q, 10K) · 02/10 22:22
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AEMD. Analyze the recent business situations of Aethlon Med through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AEMD stock price target is 7.00 with a high estimate of 8.00 and a low estimate of 6.00.
EPS
Institutional Holdings
Institutions: 33
Institutional Holdings: 590.71K
% Owned: 4.87%
Shares Outstanding: 12.12M
TypeInstitutionsShares
Increased
4
99.51K
New
5
-19.71K
Decreased
4
68.91K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.65%
Healthcare Equipment & Supplies
-0.63%
Key Executives
Chairman/Director
Edward Broenniman
Chief Executive Officer
Charles Fisher
Chief Financial Officer/Senior Vice President - Finance/Secretary/IR Contact Officer
James Frakes
Senior Vice President
Guy Cipriani
Other
Steven Larosa
Independent Director
Sabrina Johnson
Independent Director
Chetan Shah
  • Dividends
  • Splits
  • Insider Activity
No Data
About AEMD
Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.

Webull offers kinds of Aethlon Medical, Inc. stock information, including NASDAQ:AEMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AEMD stock methods without spending real money on the virtual paper trading platform.